14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.31 $4.00 Thursday, 2nd May 2024 CYCC stock ended at $2.49. This is 6.04% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 29.10% from a day low at $2.44 to a day high of $3.15.
90 days $1.31 $4.00
52 weeks $1.31 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Feb 04, 2016 $4.56 $4.56 $4.32 $4.56 4 050
Feb 03, 2016 $4.44 $4.68 $4.20 $4.56 7 475
Feb 02, 2016 $4.44 $4.56 $4.20 $4.44 3 142
Feb 01, 2016 $4.44 $4.68 $4.20 $4.32 3 392
Jan 29, 2016 $4.20 $4.68 $4.20 $4.32 9 142
Jan 28, 2016 $3.96 $4.68 $3.96 $4.20 15 042
Jan 27, 2016 $3.96 $4.32 $3.84 $4.08 5 000
Jan 26, 2016 $4.20 $4.44 $3.96 $4.20 3 342
Jan 25, 2016 $4.20 $4.44 $4.20 $4.20 2 017
Jan 22, 2016 $4.20 $4.56 $3.84 $4.20 11 242
Jan 21, 2016 $4.32 $4.32 $3.84 $4.08 5 950
Jan 20, 2016 $3.84 $4.32 $3.72 $3.96 9 058
Jan 19, 2016 $4.56 $4.80 $3.60 $3.96 15 958
Jan 15, 2016 $4.56 $4.80 $4.32 $4.44 8 308
Jan 14, 2016 $4.56 $4.80 $4.44 $4.80 11 375
Jan 13, 2016 $5.16 $5.16 $4.44 $4.44 8 450
Jan 12, 2016 $4.80 $4.80 $4.56 $4.56 8 867
Jan 11, 2016 $5.04 $5.40 $4.44 $4.56 37 483
Jan 08, 2016 $5.28 $5.40 $5.04 $5.04 8 700
Jan 07, 2016 $4.80 $5.64 $4.80 $5.16 21 842
Jan 06, 2016 $5.88 $5.88 $5.64 $5.64 15 350
Jan 05, 2016 $5.88 $6.00 $5.88 $5.88 9 508
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT